Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3MQR65
Thu, 15.05.2025
Viromed Medical AG
Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli)
Study confirms the effectiveness and safety of cold plasma therapy
Pinneberg, May 14, 2025 - Viromed Medical AG ("Viromed", FSE: VMED; ISIN: DE000A3MQR65) [ … ]
Fri, 25.04.2025
Viromed Medical AG
Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market
Pinneberg, April 25, 2025 - Viromed Medical AG ("Viromed", Ticker: VMED; ISIN: DE000A3MQR65), a medical device company and pioneer in cold plasma technology, and Landsberg First Class Aesthetic ("Landsberg"), [ … ]
Wed, 23.04.2025
Viromed Medical AG
Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor
Pinneberg, April 23, 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in wound healing, intensive care medicine and air disinfection, has gained Dr. Thomas Gutschlag, founder [ … ]
Thu, 10.04.2025
Viromed Medical AG
Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use
Pinneberg, April 10. April 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in wound healing, intensiv [ … ]
Tue, 01.04.2025
Viromed Medical AG
Viromed Medical AG: UMECO Group acquires exclusive marketing rights in Asia for cold plasma medical devices ViroCAP® and PulmoPlas®
Pinneberg, 01. April 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in air disinfection, wound healing an [ … ]
Fri, 14.03.2025
Viromed Medical AG
Viromed Medical AG reports promising study results for PulmoPlas® in intensive care unit ventilator-associated pneumonia patients
Pinneberg, Germany, March 14, 2025 - Viromed Medical AG (“Viromed”, Ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in room air sterilization, woun [ … ]
Fri, 07.03.2025
Viromed Medical AG
Viromed Medical AG: Strategic healthcare investor acquires further shares in private placement
Pinneberg, 7 March 2025 – Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) has been informed by its majority shareholder (together with his wife) and CEO Uwe Perbandt about a further off-market placement of a total of 900,000 shares from his holdings [ … ]
Fri, 28.02.2025
Viromed Medical AG
Viromed Medical AG reaches milestone for cooperation with multinational corporation
Pinneberg, 28 February 2025 –Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) has reached a milestone in the extensive cooperation with a multinational corporation announced via ad hoc notification on 11 December 2024. The subject of the agreement now concluded [ … ]
Wed, 05.02.2025
Viromed Medical AG
Viromed Medical AG: Successful placement of shares with a strategic investor in the healthcare industry to accelerate market entry in Europe
Pinneberg, 5 February 2025 –Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) was informed by its majority shareholder (together with his wife) and CEO Uwe Perbandt about the off-market placement of a tot [ … ]